Effectiveness and tolerability of the THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry (ETORO-PAIN) First published 07/10/2018 Last updated 07/10/2018 EU PAS number:EUPAS25799 Study Planned